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Dyschromatosis symmetrica hereditaria is a rare auto-
somal dominant cutaneous disorder characterized by
a mixture of hyperpigmented and hypopigmented
macules of various sizes on the face and the dorsal as-
pects of the extremities. The genetic basis for this dis-
ease is unknown.We performed a genome-wide search
in two large Chinese families to map the chromosome
location of the responsible gene.We identi¢ed a locus at
chromosome 1q11^1q21 with a cumulative maximum
two-point LOD score of 8.85 at marker D1S2343 (at
recombination fraction¼ 0.00). Haplotype analyses
indicated that the disease gene is located within the
11.6 cM region between markers D1S2696 and D1S2635.
This is the ¢rst locus identi¢ed for dyschromatosis sym-
metrica hereditaria. This study provides a map location
for isolation of a disease gene causing dyschromatosis
symmetrica hereditaria. Key words: dyschromatosis sym-
metrica hereditaria/gene mapping/genome-wide scan/linkage
analysis. J Invest Dermatol 120:776 ^780, 2003
D
yschromatosis symmetrica hereditaria (DSH)
(OMIM 127400) is also called reticulate acropig-
mentation of Dohi and symmetric dyschromatosis
of the extremities. It is usually transmitted as an
autosomal dominant pattern. But it has been
reported that DSH can also be transmitted in an autosomal reces-
sive form (Urabe and Hori, 1997; Alfadley et al, 2000). It was ¢rst
described byToyama in a Japanese family in 1929 (Toyama, 1929).
To date, most cases of DSH have been reported in the Japanese
literature (Hata and Yokomi, 1985; Taki et al, 1986; Oyama
et al, 1999). Occurrence in families of other ethnic origins such as
Chinese (Sheu andYu, 1985; He et al, 2002), Korean (Kamide et al,
1981), Indian (Hemanthkumar, 1999), English (Ostlere et al, 1995),
and South American (Costa, 1951) have also been reported.
The main features of DSH are asymptomatic small macules
scattered on the face and hyperpigmented and hypopigmented
macules on the dorsal aspects of the extremities, which appear in
infancy or early childhood. The skin lesions commonly stop
spreading before adolescence and last for life (Oyama et al, 1999).
In some cases it has been reported that the skin lesions become
more pronounced after sun exposure, but there was no evidence
of photosensitivity. Apart from the skin lesions, there are no
common associated disorders in DSH. Histologically, there is in-
creased melanin pigmentation in the basal cells of hyperpigmen-
ted lesions and the numbers of melanocytes are decreased in
hypopigmented macules (Mosher et al, 1999). Electron microscopy
showed melanocytes with high metabolic activity and many
melanosomes within melanocytes and keratinocytes in hyperpig-
mented lesions (Danese et al, 1997).
Hata and Yokomi (1985) suggested that the decrease in the
number of melanocytes is important to the pathogenesis of
DSH, and that the hypomelanosis in DSH might be because of
the low density of normal functioning melanocytes rather than
reduced melanin production in cells. The molecular basis of
DSH is unknown. Kono et al performed linkage analysis between
DSH and microsatellite markers on chromosome 9 in three
Japanese DSH families (36 patients in total), but they obtained
LOD scores of o^2 over the whole region of chromosome 9.
Thus, they concluded that there was no linkage between DSH
and chromosome 9 (Kono et al, 2000). So far, the DSH disease
gene and its chromosomal localization have not yet been identi¢ed
(Tomita et al, 2000). In this study, we undertook an entire genome-
wide scan in two families with DSH identi¢ed in Anhui province
in China. This led to mapping of the ¢rst DSH locus at 1q.
MATERIALS ANDMETHODS
Subjects Two DSH families were identi¢ed through probands from
Anhui province in China. Every family member had a signed consent
form and this study was approved by the Anhui Medical University
Review Board. All family members received careful examinations by
experienced clinical dermatologists. Clinical and histologic characteristics
supported the diagnosis of DSH. In the two families, a¡ected individuals
had no history of long-time sun exposure. After informed consent was
obtained, blood samples were collected from available family members.
Genomic DNA was extracted from peripheral blood by use of the
QIAamp DNA blood mini kit (QIAgen, Germany).
Genotyping We performed a genome-wide scan using 382 £uorescent
microsatellite markers from autosomers (ABI Prism Linkage Mapping Set
Version 2). Twenty additional microsatellite markers were selected from
Genethon linkage maps (Dib et al, 1996). The average distance between
markers for the genome scan is about 10 cM. All the markers were
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ampli¢ed by polymerase chain reaction (PCR). The reactions were
performed with a touchdown program in a 5 ml volume containing 10 ng
genomic DNA, 10 mMTris^HCl (pH 8.3), 50 mMMgCl2, 0.2 mM of each
dNTP, 0.04 mM of each primer, and 0.2 unit AmpliTaq GoldTM (Perkin
Elmer, USA). The PCR conditions were as follows: Taq activation at 941C
for 12 min, followed by 40 cycles each having denaturation at 941C for
30 s, annealing at 561C for 60 s, and extension at 721C for 90 s, except
that in the ¢rst 15 cycles the annealing temperature decreased from 631C
to 561C by 0.51C per cycle, and the ¢nal extension was 10 min. The PCR
products were loaded onto a 5% standard denaturing polyacrylamide gel
and run in an ABI Prism 377 DNA sequencer (Perkin Elmer). The size of
allele was determined on the basis of GeneScan internal lane size standards
(GeneScan-350 and GeneScan-500 ROX, Perkin Elmer). Data were
collected and analyzed with GeneScan 3.0 and Genotyper 2.1 software
(Perkin Elmer).
Linkage and haplotype analyses Autosomal dominant inheritance
with 100% penetrance was assumed. The a¡ected allele frequency was
taken as 0.0001. Marker allele frequencies were obtained from our two
families’ genotyping data. The recombination frequency was assumed to
be equal for both sexes. Two-point linkage analysis was performed using
Linkage Programs Version 5.10 (Lathrop and Lalouel, 1984). Haplotypes
were constructed with Cyrillic Version 2.02 software (Sobel and Lange,
1996) (Fig 1).
RESULTS
Clinical ¢ndings The subjects are from a four-generation DSH
family consisting of 33 individuals and a three-generation
DSH family consisting of 20 individuals. There are 27 a¡ected
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Figure1. Haplotype analysis. (1) Family 1. (2) Family 2. A¡ected and una¡ected individuals are represented by black and open symbols. Disease-gene-
bearing chromosomes are indicated with boxes. Blackened bars represent disease-carrying haplotypes.
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individuals in two families, including 15 males and 12 females.
The average age in the two families is 36.77 y, ranging from 12
to 83 y. The mean age of onset in this group is about 6.23 y. The
earliest onset of the disease in the two families was at 4 y and the
latest age of onset was 10 y. The proband of family 1 was a 27-y-
old man and at the age of 6 y he developed a small mixture of
hyperpigmented and hypopigmented macules on the backs of his
hands and feet that gradually became prominent (Fig 2a).
Depigmented spots were also scattered on his face and chest
(Fig 2b). Other a¡ected members all have a mixture of
hypopigmented and hyperpigmented macules of various sizes on
the dorsal aspects of the extremities. The proband of family 2 was
a 46-y-old male. His pigmented and depigmented spots appeared
on the dorsa of his hands and feet. After sun bathing or in the
summer, the eruptions were remarkable. His family-a¡ected
members showed similar eruptions. Skin biopsy was performed
on the proband of family 1. Masson^Fontana melanin staining
of a hyperpigmented macule on the back of his hand showed a
lot of melanin pigment both within and outside melanocytes
(Fig 3).
Two-point linkage analysis We typed available individuals of
the two DSH families with polymorphic markers on 1q.
Two-point linkage analysis of these two DSH families yielded
a supportive LOD score from the marker D1S484 (Zmax¼ 3.59,
1¼ 0.10). The two neighboring markers D1S514 (Zmax¼
2.42, 1¼0.10) and D1S218 (Zmax¼ 2.80, 1¼0.10), were also
suggestive. For ¢ne mapping, all individuals were then
genotyped with high-density markers that spanned the genetic
interval between D1S514 and D1S218. Table I summarizes the
two-point LOD scores for the markers covering the candidate
interval at various recombination fractions. The cumulative
maximum LOD score obtained was 8.85 with marker D1S2343
at a recombination fraction 1 of 0.00. LOD scores 43 were
also obtained for the other markers: D1S2696, D1S2345,
D1S2715, D1S2635, D1S484, D1S2705, and D1S2844.
Haplotype analysis To determine the smallest critical interval
containing the DSH locus, recombination events among the
family members were analyzed by haplotype reconstruction
(Fig 1 1, 2). The recombination event in individual III-8 of
family 1 places the DSH locus distal to D1S514. The crossover in
normal individual III-9 of family 2 de¢nes the DSH locus
telomeric to D1S2696. The recombination events in normal
individuals IV-2 and IV-10 in family 1 de¢ned the proximal
border of DSH to D1S2635. These results suggest that the gene
responsible for DSH lies in the 11.6 cM interval between
D1S2696 and D1S2635. (Note that the ages of IV-2 and IV-10 of
family 1 are 20 y and 16 y. The age of III-9 of family 2 is 18 y.)
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Figure1. Continued
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DISCUSSION
DSH was ¢rst described byToyama in Japan (Toyama, 1929) and
recently it has been reported in other parts of the world (Costa,
1951; Kamide et al, 1981; Ostlere et al, 1995;Tan andTay, 1997). DSH
is a rare hereditary skin disease characterized by a mixture of hy-
perpigmented and hypopigmented macules of various sizes
on the backs of the hands and feet. Some cases reported DSH
associated with idiopathic torsion dystonia (Patrizi et al, 1994;
Kono et al, 2000) and idiopathic brain calci¢cation (Tojyo et al,
2001). Oyama reviewed 185 DSH cases and reported that 77.6%
of patients had a family history and 22.4% had no family history.
The skin lesions of 73% of patients ¢rst appeared when they
were younger than 6 y of age (Oyama et al, 1999).
Dyschromatosis universalis hereditaria (DUH, OMIM 127500)
and xeroderma pigmentosum (XP, OMIM 278700) are di⁄cult
to di¡erentiate from DSH. DUH was once considered to be a
generalized form of DSH, but skin lesions appear within the ¢rst
month of life and predominantly on the trunk. Furthermore,
some pedigrees of DUH appear to show an autosomal recessive
inheritance pattern (Oyama et al, 1999). It is di⁄cult to di¡erenti-
ate DSH from XP when clinical manifestations of patients are
not fully developed (Satoh and Yoshida, 1980; Nishigori et al,
1986). Ohtoshi et al (2001) reported that DNA repair tests could
make a de¢nitive diagnosis. In our study, about half of the family
members su¡ered from DSH, showing no male or female prefer-
ence. Most of the patients developed typical skin lesions before
the age of 10 y. This property is consistent with autosomal domi-
nant inheritance. Clinical and histologic features both supported
the diagnosis of DSH.
We performed a genome-wide scan in the two DSH families
using 402 £uorescent microsatellite markers. The maximum
Table I. Two-point linkage analysis between the DSH locus and the chromosome 1p markers
LOD score at1¼
Markers Location (cM) 0.00 0.10 0.20 0.30 0.40 Zmax 1max
D1S514 157.40 8.35 2.42 2.37 1.73 0.83 2.42 0.10
D1S2696 158.50 3.73 4.60 3.66 2.48 1.17 4.60 0.10
D1S2343 160.80 8.85 7.22 5.44 3.49 1.41 8.85 0.00
D1S2345 160.80 8.54 6.94 5.19 3.29 1.30 8.54 0.00
D1S2715 164.10 4.93 4.01 3.03 1.99 0.89 4.93 0.00
D1S2635 170.10 3.02 3.95 3.08 2.01 0.86 3.95 0.10
D1S484 173.90 0.85 3.59 2.82 1.72 0.58 3.59 0.10
D1S2705 175.10 0.56 3.83 3.24 2.17 0.91 3.83 0.10
D1S2844 179.20 0.43 3.47 2.91 1.95 0.83 3.47 0.10
D1S2799 193.10 5.91 2.83 2.49 1.69 0.69 2.83 0.10
D1S218 196.50 0.17 2.80 2.36 1.62 0.73 2.80 0.10
D1S238 206.70 11.72 1.34 1.81 1.42 0.64 1.81 0.20
These LOD score values have been obtained for both pedigrees together.
LOD scores were calculated under an autosomal dominant mode of inheritance, a penetrance of 100% at various recombination fractions.
Genetic coordinates in centimorgans according to The Genethon Human Genetic Linkage Map (http://www.genethon.fr/genethon_en.html) are in the column
‘‘Location’’.
Figure 2. Clinical ¢ndings of the proband of family 1. Hyperpigmen-
ted and hypopigmented macules on the dorsal aspects of the hands and feet
(a), and ephelides-like small pigmented macules on his chest (b).
Figure 3. Biopsy of hyperpigmented macule on the back of the
hand of proband of family 1.
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LOD score obtained was 5.58 with marker D1S2343 (1¼ 0.00)
in family 1 and 3.23 with marker D1S2635 (1¼ 0.00) in family
2. The ages of individuals IV-2 and IV-10 in family 1 and III-9 in
family 2 are over the latest age of onset and we think they really
are una¡ected. It is unlikely that these individuals have not yet
manifested. So we positioned the DSH locus distal to D1S514
and proximal to D1S2635 in family 1, and in family 2 we posi-
tioned the DSH locus distal to D1S2696 and proximal to
D1S238. The overlapping region of the two families is about 11.6
cM from D1S2696 to D1S2635 and represents a physical region of
36 M bp. The cumulative maximum LOD score obtained was
8.85 with marker D1S2343 at a recombination fraction 1 of
0.00. As a result, we identi¢ed a locus on 1q11^1q21 for DSH.
There are about 389 genes within this region, including a large
number of expressed sequence tags, predicted genes, and known
genes. At present, we have not found any obvious candidate genes
that a¡ect pigment production or pigment transfer in the inter-
val. In a next step, we shall continue to reduce the candidate re-
gion by typing new markers and collecting additional DSH
families. Our results may help us to search and clone the disease
gene of DSH.
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